Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy

Rangnath Mishra, Punita Dhawan, Anand S. Srivastava, Amar B. Singh

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Inflammatory bowel disease (IBD), consisting primarily of ulcerative colitis and Crohn's disease, is a group of debilitating auto-immune disorders, which also increases the risk of colitis-associated cancer. However, due to the chronic nature of the disease and inconsistent treatment outcomes of current anti-IBD drugs (e.g., approximately 30% non-responders to anti-TNFa agents), and related serious side effects, about half of all IBD patients (in millions) turn to alternative treatment options. In this regard, mucosal healing is gaining acceptance as a measure of disease activity in IBD patients as recent studies have correlated the success of mucosal healing with improved prognosis. However, despite the increasing clinical realization of the significance of the concept of mucosal healing, its regulation and means of therapeutic targeting remain largely unclear. Here, stem-cell therapy, which uses hematopoietic stem cells or mesenchymal stem cells, remains a promising option. Stem cells are the pluripotent cells with ability to differentiate into the epithelial and/or immune-modulatory cells. The over-reaching concept is that the stem cells can migrate to the damaged areas of the intestine to provide curative help in the mucosal healing process. Moreover, by differentiating into the mature intestinal epithelial cells, the stem cells also help in restoring the barrier integrity of the intestinal lining and hence prevent the immunomodulatory induction, the root cause of the IBD. In this article, we elaborate upon the current status of the clinical management of IBD and potential role of the stem cell therapy in improving IBD therapy and patient's quality of life.

Original languageEnglish (US)
Pages (from-to)1050-1066
Number of pages17
JournalWorld Journal of Stem Cells
Issue number10
StatePublished - Oct 26 2020


  • Crohn's disease
  • Hematopoietic
  • Mesenchymal stem cells
  • Mucosal healing
  • Ulcerative colitis
  • stem cells

ASJC Scopus subject areas

  • Histology
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cell Biology


Dive into the research topics of 'Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy'. Together they form a unique fingerprint.

Cite this